ChromaGenix is a company headquartered in the United States.
ChromaGenix develops peptide ligand-based affinity purification technologies and chromatography products for bioprocessing, supplying affinity ligands and related solutions to purify complex biologics such as antibodies, AAVs, mRNA, and viral vectors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.